Fast Five Quiz: Shingles

William James, MD


December 11, 2019

According to the ACIP, because herpes zoster can recur, adults with a history of shingles should receive RZV. Vaccination should be delayed in patients experiencing an episode of herpes zoster until the acute stage is over and symptoms abate. The ACIP states that RZV may be used in adults aged 50 years or older, regardless of prior receipt of varicella vaccine or ZVL, and does not require screening for a history of chickenpox (varicella). The ACIP suggests RZV should not be given < 2 months after receipt of ZVL. ZVL is also a recommended vaccine for prevention of herpes zoster in immunocompetent adults aged 60 years or older.

Read more about the prevention of shingles.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.